These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 89175)

  • 41. An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model.
    Patel A; DiGiandomenico A; Keller AE; Smith TRF; Park DH; Ramos S; Schultheis K; Elliott STC; Mendoza J; Broderick KE; Wise MC; Yan J; Jiang J; Flingai S; Khan AS; Muthumani K; Humeau L; Cheng LI; Wachter-Rosati L; Stover CK; Sardesai NY; Weiner DB
    Nat Commun; 2017 Sep; 8(1):637. PubMed ID: 28935938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-alpha) production.
    Shirai R; Kadota J; Tomono K; Ogawa K; Iida K; Kawakami K; Kohno S
    Clin Exp Immunol; 1997 Jul; 109(1):73-9. PubMed ID: 9218827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled trials of a polyvalent pseudomonas vaccine in burns.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1979 Nov; 2(8150):977-82. PubMed ID: 91774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients.
    Meng YG; Wong T; Saravolatz LD; Pennington JE
    J Infect Dis; 1993 Mar; 167(3):784-5. PubMed ID: 8440953
    [No Abstract]   [Full Text] [Related]  

  • 45. Monovalent Pseudomonas aeruginosa vaccines in the treatment of otolaryngeal infections with Pseudomonas aeruginosa.
    Cincă D; Meitert E; Tomescu E; Meitert T; Suciu M; Sima F; Savulian C; Midan F; Lică I
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):277-84. PubMed ID: 6818930
    [No Abstract]   [Full Text] [Related]  

  • 46. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
    Speert DP; Wong SY; Macdonald M; Sargeant R
    Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infectious diseases: Two-hit antibody tackles bacteria.
    Kingwell K
    Nat Rev Drug Discov; 2015 Jan; 14(1):15. PubMed ID: 25549587
    [No Abstract]   [Full Text] [Related]  

  • 48. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine.
    Meitert T; Meitert E; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. III. Polyvalent serum against three mucoid immunotypes potentiates phagocytosis of all (7) mucoid immunotypes.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):195-203. PubMed ID: 3149178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-Pseudomonas immunoglobulin I. Immunization of sheep.
    Schiller B; Buchowicz I; Korbecki M; Lysakowska E; Rudnicka W; Robaczewska E
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):627-33. PubMed ID: 6812540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide.
    Thaden JT; Keller AE; Shire NJ; Camara MM; Otterson L; Huband M; Guenther CM; Zhao W; Warrener P; Stover CK; Fowler VG; DiGiandomenico A
    J Infect Dis; 2016 Feb; 213(4):640-8. PubMed ID: 26333940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo.
    Collins MS; Dorsey JH
    Am J Med; 1984 Mar; 76(3A):155-60. PubMed ID: 6424444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation.
    Ojielo CI; Cooke K; Mancuso P; Standiford TJ; Olkiewicz KM; Clouthier S; Corrion L; Ballinger MN; Toews GB; Paine R; Moore BB
    J Immunol; 2003 Oct; 171(8):4416-24. PubMed ID: 14530368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pseudomonas diseases.
    White A; Crowder JG
    Adv Intern Med; 1975; 20():23-35. PubMed ID: 46688
    [No Abstract]   [Full Text] [Related]  

  • 57. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa.
    Schreiber JR; Patawaran M; Tosi M; Lennon J; Pier GB
    J Immunol; 1990 Feb; 144(3):1023-9. PubMed ID: 2104908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies.
    Divithotawela C; Pham A; Ledger EL; Hopkins P; Wells TJ; Chambers D
    J Heart Lung Transplant; 2020 Jan; 39(1):87-89. PubMed ID: 31718874
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model.
    Imamura Y; Yanagihara K; Fukuda Y; Kaneko Y; Seki M; Izumikawa K; Miyazaki Y; Hirakata Y; Sawa T; Wiener-Kronish JP; Kohno S
    Eur Respir J; 2007 May; 29(5):965-8. PubMed ID: 17301098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergy of ceftazidime and human macrophages on phagocytosis and killing of Staphylococcus aureus and Pseudomonas aeruginosa.
    Cuffini AM; Carlone NA; Xerri L; Pizzoglio MF
    J Antimicrob Chemother; 1987 Aug; 20(2):261-71. PubMed ID: 3117762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.